World's Best Scientists 2026 revealed!
Journal of Enzyme Inhibition and Medicinal Chemistry
H-index 41

Journal of Enzyme Inhibition and Medicinal Chemistry

1475-6366

Published by: Taylor & Francis

https://www.tandfonline.com/toc/ienz20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Biology and Biochemistry 172 92 233 32
Chemistry 174 105 289 39

Additional Metrics

Number of Best Scientists*: 215
Documents by Best Scientists*: 359
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 98
SCIMAGO SJR: 0.857
Impact Factor: 5.4

Overview

Top Research Topics at Journal of Enzyme Inhibition and Medicinal Chemistry?

The journal covers a variety of subjects, including Biochemistry, Stereochemistry, Enzyme, In vitro and Carbonic anhydrase. It addresses concerns in Biochemistry which are intertwined with other disciplines, such as Molecular biology, Inhibitory postsynaptic potential and Pharmacology. While Stereochemistry is the focus of the journal, it also provided insights into the studies of Structure–activity relationship and Active site.

The study on Enzyme presented in it intersects with subjects under the field of Chromatography. The journal investigates In vitro research which frequently intersects with In vivo. Topics in Carbonic anhydrase explored in it were investigated in conjunction with research in Cytosol, Acetazolamide, Isozyme and Gene isoform.

The journal is concerned with the study of Antioxidant and Organic chemistry in general.

  • Biochemistry (36.16%)
  • Stereochemistry (35.65%)
  • Enzyme (22.12%)

What are the most cited papers published in the journal?

  • Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. (564 citations)
  • Structure-based drug discovery of carbonic anhydrase inhibitors. (456 citations)
  • How many carbonic anhydrase inhibition mechanisms exist (424 citations)

Research areas of the most cited articles at Journal of Enzyme Inhibition and Medicinal Chemistry:

Biochemistry, Stereochemistry, Carbonic anhydrase, Enzyme and Pharmacology are the main subjects of interest in the published papers. The journal publications explore issues in Stereochemistry which can be linked to other research areas like Antibacterial activity, Zinc and Molecule. The works on Enzyme tackled in the journal papers bring together disciplines like Chromatography and Bicarbonate.

What topics the last edition of the journal is best known for?

  • Enzyme
  • Gene
  • Organic chemistry

The previous edition focused in particular on these issues:

The topics of Biochemistry, Stereochemistry, Enzyme, Pharmacology and In vitro are the focal point of discussions in the journal. The close relationship between Cancer and Kinase and Small molecule is one of the points of interest dissected in Biochemistry research. The work on Stereochemistry tackled in the journal brings together disciplines like Potency, Acetylcholinesterase and Ring (chemistry).

Topics in Enzyme were tackled in line with various other fields like Recombinant DNA and Mycobacterium tuberculosis. It holds forums on Pharmacology that merges themes from other disciplines such as Inflammation and Inhibitory postsynaptic potential. The journal explores issues in In vitro which can be linked to other research areas like Apoptosis, In silico, Sorafenib and In vivo.

The most cited articles from the last journal are:

  • Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro . (38 citations)
  • Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. (18 citations)
  • Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Enzyme Inhibition and Medicinal Chemistry (based on the number of publications) are:

  • Claudiu T. Supuran (376 papers) published 24 papers at the last edition, 25 less than at the previous edition,
  • Clemente Capasso (63 papers) published 6 papers at the last edition, 6 less than at the previous edition,
  • İlhami Gülçin (52 papers) absent at the last edition,
  • Daniela Vullo (49 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Zahid H. Chohan (44 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Enzyme Inhibition and Medicinal Chemistry (based on the number of publications) are:

  • University of Florence (379 papers) published 23 papers at the last edition, 27 less than at the previous edition,
  • Atatürk University (123 papers) absent at the last edition,
  • King Saud University (115 papers) published 12 papers at the last edition, 1 less than at the previous edition,
  • University of Karachi (68 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Bahauddin Zakariya University (47 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 0.55% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.56% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.67% of all publications and 56.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro .

    Hongbo Liu;Fei Ye;Qi Sun;Hao Liang

    (2021)
    307 Citations
  • Benzothiazole derivatives as anticancer agents

    Ali Irfan;Fozia Batool;Syeda Andleeb Zahra Naqvi;Amjad Islam

    (2020)
    191 Citations
  • Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies

    (2022)
    158 Citations
  • Selective inhibitors for JNK signalling: a potential targeted therapy in cancer.

    Qinghua Wu;Qinghua Wu;Qinghua Wu;Wenda Wu;Wenda Wu;Vesna Jacevic;Vesna Jacevic;Tanos C. C. Franca;Tanos C. C. Franca

    (2020)
    126 Citations
  • Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

    Alessio Nocentini;Andrea Angeli;Fabrizio Carta;Jean-Yves Winum

    (2021)
    107 Citations
  • New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies

    (2022)
    97 Citations
  • Advances in the discovery of exosome inhibitors in cancer

    Huarui Zhang;Jun Lu;Jun Lu;Jin Liu;Ge Zhang

    (2020)
    97 Citations

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens doors to diverse career opportunities across healthcare, research, and industry. Students can explore healthcare administration online programs to develop leadership and management skills vital for running medical facilities and healthcare organizations. These programs offer practical, flexible options for those interested in combining science with administrative expertise.

For biology majors seeking lucrative career paths, there are numerous options highlighted in the list of 20 careers in biology salary. Positions in biotechnology, pharmaceuticals, and environmental science offer competitive pay and job growth, reflecting the versatile applications of biology knowledge.

Students looking for flexible learning methods can benefit from several online biology degree programs. These accelerated courses help aspiring biologists graduate faster without compromising the quality of education, making them ideal for those balancing work or personal commitments.

Additionally, specialized fields like exercise science are accessible through reputable exercise science degrees online. These programs equip students with knowledge about human physiology and wellness, preparing them for careers in fitness, rehabilitation, or sports medicine.

Best Scientists Contributing to This Journal